EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.
EVerZom has raised €11M across 2 funding rounds from 7 investors, most recently a round in Oct 2025. Based in Paris, France; founded 1919; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-10-14 | Other | €10M | Aloe Private Equity,Capital Cell platform,Capital Grand Est,Family Offices,Paris Business Angels,Sorbonne Venture+1 more | View deal → |
| 2020-12-01 | Other | €1.1M | — | View deal → |
